NOSTRAND ROBERT L VAN Insider Trading $ACHN ACHILLION PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NOSTRAND ROBERT L VAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NOSTRAND ROBERT L VAN. NOSTRAND ROBERT L VAN is VP, & Chief Financial Officer in OSI PHARMACEUTICALS INC ($OSIP) and Director in METABOLIX, INC. ($MBLX) and in ACHILLION PHARMACEUTICALS INC ($ACHN) and Director in ACHILLION PHARMACEUTICALS INC ($ACHN) and Director in SELLAS Life Sciences Group, Inc. ($GALE) and Director in Enumeral Biomedical Holdings, Inc. ($ENUM) and Director in Intra-Cellular Therapies, Inc. ($ITCI).
NOSTRAND ROBERT L VAN in ACHILLION PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NOSTRAND ROBERT L VAN:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 29 2020
$ACHN Market Capitalization: $579.52M
$ACHN Previous Close: $4.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NOSTRAND ROBERT L VAN in ACHILLION PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHN, ENUM, ITCI, OSIP, SLS, MBLX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 2.18 | 42,000 | 91,560 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 2.90 | 30,000 | 87,000 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 3.02 | 25,000 | 75,500 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 3.10 | 50,000 | 155,000 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 4.09 | 30,000 | 122,700 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 7.54 | 30,000 | 226,200 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 7.59 | 20,000 | 151,800 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Sell | D | 6.30 | 40,000 | 252,000 | 0 | 40 K to 0 (-100.00 %) | |
| Dec 19 2019 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | M | 3.28 | 20,000 | 65,600 | 0 | ||
| Dec 19 2019 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Buy | M | 3.28 | 20,000 | 65,600 | 40,000 | 20 K to 40 K (+100.00 %) | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 2.18 | 42,000 | 91,560 | 42,000 | |
| Dec 18 2018 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | M | 1.05 | 20,000 | 21,000 | 0 | |
| Dec 18 2018 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Buy | M | 1.05 | 20,000 | 21,000 | 20,000 | 0 to 20 K |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 4.09 | 30,000 | 122,700 | 30,000 | |
| Jan 27 2016 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 7.54 | 30,000 | 226,200 | 30,000 |
Page: 1